Open Actively Recruiting

VIRTUUS Children's Study

About

Brief Summary

The objective of the VIRTUUS Children's Study is to adapt identified and validated adult noninvasive diagnostic and prognostic biomarkers for the characterization of allograft status in pediatric recipients of kidney allografts.

Study Type
Observational

Eligibility

Gender
All
Minimum Age
2 Years
Maximum Age
18 Years

Inclusion Criteria:

  • Males or females between 2 to 18 years at the time of recruitment
  • Receiving the first, or additional, incident kidney transplants.
  • Have an existing/prevalent transplant with a scheduled kidney allograft biopsy.
  • Parental/guardian permission (informed consent) and, if appropriate, child assent.

Exclusion Criteria:

  • Patient's primary medical team feels the subject's participation is not safe.

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
17-001431
Category
Pediatrics
Contact
Barbara Gales
Location
  • UCLA Westwood
For Providers
NCT No.
NCT03719339
For detailed technical eligibility, visit ClinicalTrials.gov.